Possible agent for COVID-19 treatment: Rifampicin
Rifampicin is a promising drug for the treatment of coronavirus disease 2019 based on its antiviral properties and recent studies. studies can serve as a foundation for further studies.
Saved in:
Published in | World journal of virology Vol. 11; no. 5; pp. 391 - 393 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Baishideng Publishing Group Inc
25.09.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Rifampicin is a promising drug for the treatment of coronavirus disease 2019 based on its antiviral properties and recent
studies.
studies can serve as a foundation for further studies. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Author contributions: Aydın S, Aydin OC and Barun S conceived the study; Aydın S, Aydin OC and Barun S were responsible for designing, materials and supervision; Aydın S, Aydin OC and Barun S did the literature search, wrote the manuscript, and reviewed the manuscript critically; All authors have read and approved the final manuscript. Corresponding author: Ozlem Celik Aydin, MD, Doctor, Department of Medical Pharma-cology, Erzincan University, Mengucek Gazi Education and Research Hospital, Başbağlar Mahallesi Hacı Ali Akın Caddesi No. 32 Erzincan/Merkez, Erzincan 24100, Turkey. ozlemclk_89@hotmail.com |
ISSN: | 2220-3249 2220-3249 |
DOI: | 10.5501/wjv.v11.i5.391 |